BayWa's Restructuring Plan Faces Mounting Challenges

BayWa sells Cefetra, cutting debt by €600M, but its renewable energy unit underperforms, delaying its annual report and casting doubt on 2028 recovery targets.

The German conglomerate BayWa has achieved a significant milestone in its ongoing corporate overhaul, yet the path to its 2028 recovery targets appears increasingly uncertain. While the sale of a key subsidiary has provided balance sheet relief, unexpected underperformance in a core business unit and executive turnover are casting doubt on the restructuring timeline.

Debt Reduction Advances with Cefetra Divestment

A major step in BayWa's deleveraging strategy has been finalized with the completion of the Cefetra Group B.V. sale. Announced in December 2025, the transaction with an investor consortium fetched a purchase price of 125 million euros. The more substantial impact, however, stems from deconsolidation: the company reports a reduction in financial liabilities exceeding 600 million euros. Proceeds from the sale are earmarked for direct debt repayment.

This move contributes to a broader debt reduction effort. Combined with other divestments completed in 2025—including RWA, WHG, and EDL—the group has lowered its bank debt by approximately 1.3 billion euros since that year. Nevertheless, this progress remains distant from the plan's ultimate objective: reducing total debt by 4 billion euros by 2028.

Operational Downsizing Continues; Next Asset Sale on Deck

Concurrent with its financial restructuring, BayWa is executing a operational scale-down. The company aims to reduce annual revenue to about 10 billion euros by 2028. Workforce reductions are also underway, with plans to cut roughly 1,300 positions by 2027, including a 40% reduction in central administration roles. Furthermore, the group intends to shutter 26 out of more than 400 global branches.

The next planned divestment involves the New Zealand-based subsidiary Turners & Growers (T&G Global), with a sale targeted for 2026.

Core Renewable Energy Unit Stumbles, Delays Annual Report

Despite the progress from the Cefetra sale, a significant challenge has emerged. The renewable energy subsidiary BayWa r.e., considered a cornerstone for future refinancing, is performing substantially below plan. On February 2, BayWa issued an ad-hoc announcement citing "significant deviations" from its business plan, attributing the shortfall to "tangible market changes" in the renewable energy sectors of the U.S. and Europe.

This development has direct financial consequences. The planned total proceeds from the intended sale of the stake by the end of 2028 are now expected to be lower. As a result, the company may need to revise its restructuring assessment.

An immediate operational impact is a delay in financial reporting. The publication of the 2025 annual report, originally scheduled for no later than the end of April 2026, is now expected to be postponed.

Leadership Exodus and Regulatory Scrutiny Add to Instability

Management stability is also in flux. The former CEO, Dr. Frank Hiller, will depart on July 31, 2026 "by mutual agreement," with his role as Chairman of the Management Board ending immediately. Several supervisory board members have also announced their departures: Monika Hohlmeier and Michael Höllerer will leave at the end of March, followed by Monique Surges at the end of May.

In a move to tighten governance, the conglomerate has lowered the threshold for supervisory board approval on transactions. Deals exceeding 50 million euros now require board consent, down from the previous threshold of 200 million euros.

Adding another layer of complexity, the German financial regulator, BaFin, has been examining the 2023 annual accounts since October 2024. This scrutiny follows a fine imposed by the Federal Office of Justice for delayed data submission.

Investors will soon gain more clarity. BayWa is scheduled to release its Q4 2025 figures on March 26. This update is anticipated to reveal the full extent of the deviations at BayWa r.e. and assess the remaining viability of the schedule for finalizing the 2025 accounts.